New Federal Contractors — July 24, 2026

Leidos Holdings subsidiary won a cost-plus-fixed-fee delivery order from NIH for Phase 1/2 vaccine trials through 2029, with $36.8M already funded, providing stable, low-volatility revenue.

Frequentis USA secured a time-and-materials delivery order for APC units and APCMS, with $105.1M already outlayed, indicating high funding certainty and stable demand through 2027.

PTSI’s firm-fixed-price contract for Goddard facility design/construction is 78% paid and ended in 2023, creating a revenue gap risk if no new NASA awards are won.

All four contracts are civilian (HHS, NASA, FAA), with zero defense exposure. Civilian agencies face higher budget uncertainty under continuing resolutions and potential sequestration, unlike DOD’s protected funding.

PTSI Managed Services’ $130.8M NASA firm-fixed-price contract is substantially complete (78% paid) with no visible follow-on, creating revenue dependency risk for the company.

Frequentis USA’s $124.6M FAA delivery order was awarded under full and open competition with no set-aside, meaning the company faces re-compete risk against larger telecom/IT contractors.

Leidos Biomedical’s $173.3M NIH contract for vaccine trials positions the company for follow-on work if Phase 1/2 trials succeed, potentially expanding into Phase 3 or commercial production.

Raytheon’s $113.2M sole-source FAA delivery order under the STARS program confirms its entrenched incumbent position, creating opportunities for follow-on modifications or extensions.

Three of four contracts (NASA Goddard facilities, FAA APCMS, FAA ground handling equipment) involve physical or telecom infrastructure upgrades, indicating sustained civilian investment in aging federal assets.

Leidos Biomedical’s $173.3M cost-plus contract for vaccine trials demonstrates NIH’s consistent funding for health R&D, even amid broader budget uncertainty.

{"entity" => "Leidos Holdings (LDOS)", "reason" => "Won the highest-value contract ($173.3M) with low-risk pricing; future obligations under the delivery order will determine full revenue realization.", "trigger" => "NIH funding obligation announcements for Phase 2 trial expansion"}

{"entity" => "PTSI Managed Services", "reason" => "Its $130.8M NASA contract is 78% complete with no visible follow-on, creating revenue gap risk.", "trigger" => "New NASA Goddard facility contract awards or modifications"}

{"entity" => "Frequentis USA", "reason" => "Won $124.6M FAA delivery order under full competition; re-compete risk and foreign ownership scrutiny are key watch items.", "trigger" => "FAA APCMS re-compete announcement or regulatory changes affecting foreign-owned contractors"}

{"entity" => "Raytheon Technologies (RTX)", "reason" => "Sole-source $113.2M FAA contract confirms incumbency but is immaterial to RTX’s $69B+ revenue; watch for STARS program follow-ons.", "trigger" => "FAA STARS program budget allocations or contract modifications"}